DiNuzzo Private Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

DiNuzzo Private Wealth’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41K	Hold	8	–	–	﹤0.01%	608
2026 Q1	$2.65K	Hold	8	–	–	﹤0.01%	549
2025 Q4	$3.18K	Hold	8	–	–	﹤0.01%	486
2025 Q3	$3.57K	Sell	8 -4	-33%	-$1.63K	﹤0.01%	453
2025 Q2	$3.91K	Buy	12 +2	+20%	+$553	﹤0.01%	426
2025 Q1	$2.7K	Buy	10 +3	+43%	+$771	﹤0.01%	503
2024 Q4	$1.65K	Hold	7	–	–	﹤0.01%	669
2024 Q3	$1.93K	Hold	7	–	–	﹤0.01%	623
2024 Q2	$1.7K	Buy	7 +1	+17%	+$158	﹤0.01%	578
2024 Q1	$897	Hold	6	–	–	﹤0.01%	777
2023 Q4	$1.15K	Buy	+6	New	+$1.02K	﹤0.01%	652

Other funds holding ALNY

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

DiNuzzo Private Wealth's ALNY Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 8 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

DiNuzzo Private Wealth first reported a position in ALNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.91K in Q2 2025. 217 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

DiNuzzo Private Wealth held 8 shares of Alnylam Pharmaceuticals worth $2.41K as of Q2 2026.
DiNuzzo Private Wealth left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
Alnylam Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #608 holding.
DiNuzzo Private Wealth first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
DiNuzzo Private Wealth's Alnylam Pharmaceuticals position peaked at $3.91K in Q2 2025.
217 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.